Shiwei Liu is a biologist with a research background in cell biology, genomics, microscopy-based biotechnologies, and gene therapy.
Prior to joining Jones Day in 2025, Shiwei conducted post-doctoral research in spatial genomics at Harvard University and completed his Ph.D. at Harvard Medical School/Harvard University, where his work examined the relationship between cancer cell division and genome instability. He also gained industry experience as a scientist at Qilu Pharmaceuticals, where he developed gene therapies for human diseases. He has authored several peer-reviewed publications in the fields of cancer, cell biology, and genomics.
- Harvard University (Ph.D. in Biological and Biomedical Sciences 2019); Fudan University (B.S. in Biological Sciences 2012)
- Registered to practice before the United States Patent and Trademark Office
Before sending, please note:
Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.